Jerzy Gruhn
Corporate Officer/Principal at European Association For The Study of Diabetes
Profile
Jerzy Gruhn is a member of the European Association For The Study of Diabetes.
He previously worked as a Director at Pharmaceutical Research & Manufacturers of America, Senior Vice President & Head-Europe Region at Novo Nordisk A, and President at Novo Nordisk, Inc. He graduated from the University of Warsaw in 1990.
Jerzy Gruhn active positions
Companies | Position | Start |
---|---|---|
European Association For The Study of Diabetes | Corporate Officer/Principal | - |
Former positions of Jerzy Gruhn
Companies | Position | End |
---|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | President | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | - |
NOVO NORDISK A/S | Corporate Officer/Principal | - |
Training of Jerzy Gruhn
University of Warsaw | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NOVO NORDISK A/S | Health Technology |
Private companies | 3 |
---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
European Association For The Study of Diabetes | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
- Stock Market
- Insiders
- Jerzy Gruhn